Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa

A multicenter, retrospective study of patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane/tazobactam was performed. Among 35 patients, pneumonia was the most common indication and treatment was successful in 26 (74%). Treatment failure was observed in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Infect Dis
Asıl Yazarlar: Munita, Jose M, Aitken, Samuel L, Miller, William R, Perez, Federico, Rosa, Rossana, Shimose, Luis A, Lichtenberger, Paola N, Abbo, Lilian M, Jain, Rupali, Nigo, Masayuki, Wanger, Audrey, Araos, Rafael, Tran, Truc T, Adachi, Javier, Rakita, Robert, Shelburne, Samuel, Bonomo, Robert A, Arias, Cesar A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2017
Konular:
Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850333/
https://ncbi.nlm.nih.gov/pubmed/28329350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix014
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller